Edwards Lifesciences EW Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's total liabilities & equity?
- Edwards Lifesciences (EW) reported total liabilities & equity of $13.32B in Q1 2026.
- How has Edwards Lifesciences's total liabilities & equity changed year-over-year?
- Edwards Lifesciences's total liabilities & equity increased by 2.3% year-over-year, from $13.02B to $13.32B.
- What is the long-term trend for Edwards Lifesciences's total liabilities & equity?
- Over 5 years (2020 to 2025), Edwards Lifesciences's total liabilities & equity has grown at a 13.6% compound annual growth rate (CAGR), from $7.24B to $13.7B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.